Skip to main content

Mission & Strategy

direction2.jpg

 

From left to right: Olivier Neyrolles (PhD, Deputy Director), Alain Milon (PhD, Deputy Director), Jean-Philippe Girard (PhD, Director), Mylène Martin (General Secretary)

 

Toulouse and the Occitanie Region, a rich environment for scientists…

Situated between the Mediterranean Sea and the Atlantic Ocean, in the heart of Southern France and close to the Pyrenees mountain range, Toulouse has long been a major crossroad in Europe. Attracting 15,000 newcomers every year, Toulouse, the capital of the Occitanie region has been growing fast both demographically and economically. It boasts a particularly rich and vibrant cultural and artistic heritage.

Within the leading French region for research and innovation - with around 30, 000 researchers and 3.7 % of its GDP spent on research (2014) – Toulouse has an international reputation for its cutting-edge aerospace, agronomic, health and economic research centers. Over 110, 000 students, among whom 11, 000 come from all over the world, pursue their studies in Toulouse, one of the most dynamic student cities in France.

The Institute of Pharmacology and Structural Biology (Institut de Pharmacologie et de Biologie Structurale, IPBS) is a joint research centre of the CNRS and the University of Toulouse.

 

Occupying 12,000 m2 in the heart of the main campus of the University Toulouse III-Paul Sabatier, which offers a multidisciplinary education in the fields of Science, Health and Enginerering, the IPBS is part of one of the most important scientific research clusters in France.

 

IPBS is currently home to more than 250 scientific and administrative staff, who benefit greatly from a highly collaborative and innovative environment.

 

Currently, 17 research groups are organised into three research departments (Cancer Biology, Structural Biology and Biophysics, Tuberculosis and Infection Biology), and four in-house technological core facilities.

 

The IPBS is a world leader in the discovery, characterization and validation of novel biological targets in the fields of cancer and infectious diseases. These discoveries are made through the use of molecular and cellular biology approaches, together with in vivo experiments, including BSL-3-based studies of infectious diseases. IPBS conducts state-of-the-art research in structural biology, proteomics, biophysics, cancerology, immunology and microbiology. 

 

We, the Directors of the IPBS, are extremely proud of the achievements of the Institute to date. We hope to keep our institute deeply embedded in both national and international networks, with strong connections with industry and clinics in order to ensure the best environment for the further development of knowledge, technology and innovation. Our primary mission is to train and attract the next generation of researchers while also promoting science among the general public.